Mather Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Buy
1,191
+62
+5% +$16.3K ﹤0.01% 639
2026
Q1
$301K Buy
1,129
+92
+9% +$24.9K ﹤0.01% 617
2025
Q4
$260K Sell
1,037
-51
-5% -$13.5K ﹤0.01% 556
2025
Q3
$312K Buy
1,088
+57
+6% +$15.3K ﹤0.01% 509
2025
Q2
$271K Buy
1,031
+33
+3% +$8.04K ﹤0.01% 524
2025
Q1
$232K Buy
998
+181
+22% +$43.9K ﹤0.01% 548
2024
Q4
$187K Buy
817
+290
+55% +$66.5K ﹤0.01% 587
2024
Q3
$118K Sell
527
-104
-16% -$22.9K ﹤0.01% 702
2024
Q2
$138K Buy
631
+5
+0.8% +$1.02K ﹤0.01% 715
2024
Q1
$142K Buy
+626
New +$138K ﹤0.01% 612
2023
Q3
Sell
-1,019
Closed -$211K 583
2023
Q2
$211K Buy
+1,019
New +$198K ﹤0.01% 541
2022
Q1
Sell
-758
Closed -$204K 459
2021
Q4
$204K Buy
+758
New +$188K ﹤0.01% 382

Other funds holding LH

Mather Group's LH Position: Q2 2026 in Review

Mather Group increased its Labcorp (LH) stake by 5.5% in Q2 2026, buying an estimated $16.3K and bringing the position to 1,191 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #639.

Mather Group first reported a position in LH in Q4 2021 and has held it in 12 quarters since. 338 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Mather Group held 1,191 shares of Labcorp worth $333K as of Q2 2026.
  • Mather Group bought 62 Labcorp shares in Q2 2026, an estimated $16.3K.
  • Labcorp made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #639 holding.
  • Mather Group first reported a position in Labcorp in Q4 2021 and has held it in 12 quarters since.
  • 338 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.